K-Ras gene mutation status as a prognostic and predictive factor in patients with colorectal cancer undergoing irinotecan- or oxaliplatin-based chemotherapy.
Journal Information
Full Title: Cancer Biol Ther
Abbreviation: Cancer Biol Ther
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Disclosure of Potential Conflicts of Interest The authors declare that they have no competing interests."
Funding Disclosure
Evidence found in paper:
"Sources of support: Support from the Military Institute of The Health Services, Warsaw, Poland, Grant No. WIM-50/2008 and WIM-45/2009."
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025